HUE036840T2 - Eljárás botulinum toxin elõállítására - Google Patents

Eljárás botulinum toxin elõállítására

Info

Publication number
HUE036840T2
HUE036840T2 HUE14832966A HUE14832966A HUE036840T2 HU E036840 T2 HUE036840 T2 HU E036840T2 HU E14832966 A HUE14832966 A HU E14832966A HU E14832966 A HUE14832966 A HU E14832966A HU E036840 T2 HUE036840 T2 HU E036840T2
Authority
HU
Hungary
Prior art keywords
production
botulinum toxin
botulinum
toxin
Prior art date
Application number
HUE14832966A
Other languages
English (en)
Hungarian (hu)
Inventor
Chung Sei Kim
Kwan Young Song
Kyoung Min Min
Yeong Duk An
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49987856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE036840(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of HUE036840T2 publication Critical patent/HUE036840T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
HUE14832966A 2013-08-02 2014-05-07 Eljárás botulinum toxin elõállítására HUE036840T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130092024A KR101339349B1 (ko) 2013-08-02 2013-08-02 보툴리눔 독소의 제조방법

Publications (1)

Publication Number Publication Date
HUE036840T2 true HUE036840T2 (hu) 2018-08-28

Family

ID=49987856

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14832966A HUE036840T2 (hu) 2013-08-02 2014-05-07 Eljárás botulinum toxin elõállítására

Country Status (25)

Country Link
US (1) US9512418B2 (en:Method)
EP (1) EP2920199B1 (en:Method)
JP (2) JP6307150B2 (en:Method)
KR (1) KR101339349B1 (en:Method)
CN (1) CN105392795B (en:Method)
AR (1) AR096541A1 (en:Method)
AU (1) AU2014297167B2 (en:Method)
BR (1) BR112015029973B1 (en:Method)
CA (1) CA2912553C (en:Method)
CY (1) CY1120410T1 (en:Method)
DK (1) DK2920199T3 (en:Method)
ES (1) ES2665288T3 (en:Method)
HR (1) HRP20180679T1 (en:Method)
HU (1) HUE036840T2 (en:Method)
LT (1) LT2920199T (en:Method)
MX (1) MX362821B (en:Method)
NO (1) NO2920199T3 (en:Method)
PH (1) PH12015501855A1 (en:Method)
PL (1) PL2920199T3 (en:Method)
PT (1) PT2920199T (en:Method)
RU (1) RU2627159C2 (en:Method)
SA (1) SA515370208B1 (en:Method)
SG (1) SG11201509486VA (en:Method)
SI (1) SI2920199T1 (en:Method)
WO (1) WO2015016462A1 (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법
KR101723167B1 (ko) 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101729251B1 (ko) 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723168B1 (ko) 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101853463B1 (ko) * 2015-09-09 2018-06-20 휴젤(주) 보툴리눔 독소의 정제 방법
KR101775682B1 (ko) 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
CN109641941B (zh) * 2016-05-16 2023-06-16 哈佛大学校长及研究员协会 用于纯化和激活肉毒杆菌神经毒素的方法
KR102463881B1 (ko) 2016-10-04 2022-11-07 (주)메디톡스 보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
KR101744900B1 (ko) 2017-01-20 2017-06-08 주식회사 대웅 보툴리눔 독소를 포함하는 안정한 액상 조성물
CN109646673A (zh) * 2017-10-12 2019-04-19 秀杰股份公司 肉毒杆菌毒素的微结构制剂技术
CA3124535A1 (en) 2018-12-21 2020-06-25 The Research Foundation For Microbial Diseases Of Osaka University Botulinum toxin producing method
KR102516204B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 정제방법
KR102516203B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 제조방법
TWI854077B (zh) * 2019-12-20 2024-09-01 瑞士商葛德瑪控股公司 生產肉毒桿菌毒素的方法
TW202136286A (zh) * 2019-12-20 2021-10-01 瑞士商葛德瑪控股公司 純化肉毒桿菌毒素的方法
KR102724651B1 (ko) * 2021-07-08 2024-11-01 주식회사 파마리서치바이오 비-독소 단백질이 제거된 클로스트리디움 보툴리눔 신경독소 단백질의 정제방법
TWI852454B (zh) * 2022-04-01 2024-08-11 大陸商重慶譽顏製藥有限公司 一種肉毒毒素蛋白組合物、製備方法及其應用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030060150A (ko) * 2002-01-07 2003-07-16 (주)메디톡스 클로스트리디움 보툴리눔 a형 독소를 정제하는 방법
RU2206337C1 (ru) * 2002-10-29 2003-06-20 Общество с ограниченной ответственностью "Токсины и сопутствующие продукты" Лекарственный препарат для лечения мышечных дистоний и способ его получения
US7452697B2 (en) * 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
US7879341B2 (en) * 2004-07-26 2011-02-01 Merz Pharma Gmbh & Co. Kgaa Therapeutic composition with a botulinum neurotoxin
AU2005327458B2 (en) * 2005-03-03 2011-12-15 Allergan, Inc. Animal product free system and process for purifying a botulinum toxin
KR101025617B1 (ko) * 2008-02-25 2011-03-30 메덱스젠 주식회사 클로스트리디움 보툴리눔으로부터 보툴리눔 독소를정제하는 방법
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
HRP20181869T1 (hr) * 2009-10-21 2019-01-11 Revance Therapeutics, Inc. Metode i sustavi za pročišćavanje nekompleksiranog botulinskog neurotoksina
KR101434558B1 (ko) * 2011-07-21 2014-08-27 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여 클로스트리디움 보툴리눔 독소를 생산하는 방법
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
US20150337281A1 (en) 2015-11-26
ES2665288T3 (es) 2018-04-25
CN105392795A (zh) 2016-03-09
PL2920199T3 (pl) 2018-08-31
EP2920199B1 (en) 2018-03-07
KR101339349B1 (ko) 2013-12-09
JP2017141237A (ja) 2017-08-17
MX362821B (es) 2019-02-18
RU2015151186A (ru) 2017-06-01
PT2920199T (pt) 2018-05-30
WO2015016462A1 (en) 2015-02-05
HRP20180679T1 (hr) 2018-06-01
SI2920199T1 (en) 2018-06-29
CN105392795B (zh) 2019-11-22
CA2912553A1 (en) 2015-02-05
AU2014297167A1 (en) 2015-12-10
BR112015029973A2 (pt) 2017-07-25
BR112015029973B1 (pt) 2023-01-17
CY1120410T1 (el) 2019-07-10
AU2014297167B2 (en) 2016-11-17
RU2627159C2 (ru) 2017-08-03
JP6307150B2 (ja) 2018-04-04
SA515370208B1 (ar) 2017-07-08
LT2920199T (lt) 2018-04-10
US9512418B2 (en) 2016-12-06
HK1215715A1 (zh) 2016-09-09
EP2920199A1 (en) 2015-09-23
PH12015501855B1 (en) 2015-12-07
PH12015501855A1 (en) 2015-12-07
CA2912553C (en) 2018-01-02
JP2016521968A (ja) 2016-07-28
DK2920199T3 (en) 2018-05-28
AR096541A1 (es) 2016-01-13
MX2015016481A (es) 2016-06-10
NO2920199T3 (en:Method) 2018-08-04
SG11201509486VA (en) 2015-12-30
EP2920199A4 (en) 2016-10-05

Similar Documents

Publication Publication Date Title
SG11201509486VA (en) Method for production of botulinum toxin
PL3563793T3 (pl) Aparat ortodontyczny oraz sposób jego wytwarzania
PL3006568T3 (pl) Sposób wytwarzania tagatozy
IL242695B (en) Device for the production of molybdenum-99
GB201401248D0 (en) Method of manufacture
SG11201602587TA (en) Method for producing instant noodles and instant noodles
EP3004213A4 (en) Method of making polybenzimidazole
SG11201507875RA (en) Protein production method
HUE047395T2 (hu) Eljárás javított kiolvasztásra
SG11201507528YA (en) Production method of 1,3-butadiene
GB201411844D0 (en) Improved method of additive manufacturing
GB2519372B (en) Machine and method of operation
GB201305231D0 (en) Method of Manufacture
SG11201604277QA (en) Method for producing instant noodles
GB201318670D0 (en) Machine and method of operation
EP3048083A4 (en) Production method for hematite for iron production
IL240471A0 (en) Method of production of pyridizinone compounds
GB201301384D0 (en) Method for antibody production
GB201404594D0 (en) Improved method of data dependent control
PL3004997T3 (pl) Sposób sterowania procesem
GB201319961D0 (en) Method of filtering product ions
GB201303264D0 (en) Method of control
TWI562212B (en) A method of forming a gate contact
GB201311291D0 (en) Method of manufacture
GB201301262D0 (en) Method of manufacture